Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Preliminary result of a phase Ib study: Efficacy and safety of FG-M108 plus gemcitabine and nab-paclitaxel in patients with Claudin18.2 positive locally advanced unresectable or metastaticpancreatic cancer
Liu, F.; Zhang, Y.; Zhang, S.; Gong, J.; Zhang, M.; Liang, X.; Wang, J.; Li, Y.; Jin, Z.; Yang, Y.; Shen, L. Share Save A phase I/II study of FG-M108 plus capecitabine and oxaliplatin (CAPOX) as first-line (1L) treatment for patients with CLDN18.2+/HER2-advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinomaGong, J.; Liu, F.; Jin, Z.; Zhang, M.; Zhang, S.; Zhang, Y.; Liang, X.; Li, Y.; Yang, Y.; Shen, L. Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
